Mary-Claire King on BRCA, Nobel Watch, and Saving Lives — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Mary-Claire King identified mutations in the BRCA1 and BRCA2 genes in 1994 and 1995, proving they dramatically increase the risk of hereditary breast and ovarian cancer
- Mary-Claire King was invited to give a seminar at the Karolinska Institutet two decades ago, a known signal that she was under consideration for the Nobel Prize in Physiology or Medicine
- Women with BRCA mutations can take preventive action such as mastectomies or removal of ovaries and fallopian tubes, decisions that have reduced cancer mortality for thousands
- Mary-Claire King receives personal letters from women worldwide who credit her work with saving their lives, including one who shared a photo of her daughter’s high school graduation after preventive surgeries
- Mary-Claire King advises young scientists to pursue problems that are personally meaningful, noting that small research questions can grow into major medical advances over time
- Mary-Claire King continues active research at the University of Washington, focusing on de novo mutations in schizophrenia, structural variations in cancer, and inherited mental health disorders
Why it matters: King’s work has enabled life-saving interventions for hundreds of thousands at genetic risk for cancer, yet despite widespread recognition and real-world impact, she has not received the Nobel Prize — a gap that underscores how transformative public health contributions can remain formally unrewarded even as they reshape medicine and patient outcomes globally.
Ask SkimNews
